Twinbeech Capital LP Care Dx, Inc. Transaction History

Twinbeech Capital LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$4.9 - $12.86 $471,718 - $1.24 Million	-96,269 Reduced 65.98%	49,634 $595,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $24,577 - $39,533	-3,511 Reduced 2.35%	145,903 $1.02 Million
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $1.14 Million - $1.41 Million	149,414 New	149,414 $1.27 Million
Q4 2021 Feb 14, 2022	SELL	$41.2 - $73.6 $193,640 - $345,920	-4,700 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $278,005 - $432,353	4,700 New	4,700 $298,000
Q1 2020 May 15, 2020	SELL	$13.94 - $28.25 $175,379 - $355,413	-12,581 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.24 - $28.41 $242,058 - $357,426	12,581 New	12,581 $271,000

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.15B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Twinbeech Capital LP, based on Form 13F filings with the SEC.

Stay updated on Twinbeech Capital LP with notifications on news.